Abstract
The COVID-19 pandemic has been ongoing for close to a year, with second waves occurring presently and many viewing a vaccine as the most likely way to curb successive waves and promote herd immunity. Reaching herd immunity status likely necessitates that children, as well as their parents, receive a vaccine targeting SARS-CoV-2. In this exploratory study, we investigated the demographic, experiential, and psychological factors associated with the anticipated likelihood and speed of having children receive a SARS-CoV-2 vaccine in a sample of 455 Canadian families (857 children). Using linear mixed effects and proportional odds logistic regression models, we demonstrated that older parental age, living in the Prairies (relative to Central Canada), more complete child and parental vaccination history, more positive attitudes towards vaccines generally, higher psychological avoidance of the pandemic and a greater tendency to prioritize the risks of the disease relative to the risks of side effects (i.e., lower omission bias), were associated with higher likelihoods of intention to vaccinate participants’ children. In some models, subjective evaluations of proximal COVID-19 risk and higher levels of state anxiety were associated with increased likelihood of having children vaccinated. Faster speed of intended vaccination was predicted by a similar constellation of variables, with higher SES emerging as a trend-level predictor of vaccination speed. Results are discussed with respect to public health knowledge mobilization.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The research was supported by an internal Rapid Response Grant to CLL from Mount Saint Vincent University (Halifax, Canada).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Mount Saint Vincent University (Halifax, Canada) University Research Ethics Board
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Note: Ethical clearance was obtained from the Mount Saint Vincent University Research Ethics Board, according to the TriCouncil Policy Statement: Ethical Conduct for Research Involving Humans.
Data Availability
Data are not publicly available.
